Key highlights Torrance, California
90480 Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, single dose (for all ages) 91318 (Pfizer) Severe acute respiratory coronavirus 2 (SARS-CoV-2-) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, 3 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation, for intramuscular use (6 months through 4 years) 91319 (Pfizer) Severe acute respiratory coronavirus 2 (SARS-CoV-2-) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation, for intramuscular use (5 years through 11 years) 91320 (Pfizer) Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, 30 mcg/0.3 mL dosage, tris-sucrose formulation, for intramuscular use (12 years and older) 91321 (Moderna) Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, 25 mcg/0.25 mL dosage, for intramuscular use (6 months through 11 years) 91322 (Moderna) Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, 50 mcg/0.5 mL dosage, for intramuscular use (12 years and older) Respiratory Syncytial Virus (RSV) Vaccine CPT Codes Adults 65 and over and adults with chronic conditions or weakened immune systems are at high risk for developing severe RSV
Although the thought of every day injections was daunting to start with, the positive effects it had on my well-being, far outweighs the downside of having to inject daily. Alex, 38
Thus, by silencing CDO1, NRF2-addicted cancer cells maintain a large intracellular pool of cysteine for the glutathione synthesis, resulting from the increased cysteine uptake by xCT and decreased cysteine decomposition
